Cargando…

Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells, Compared with Human Pancreatic Islets and Immortalized β Cell Line

BACKGROUND: New sources of insulin-secreting cells are strongly in demand for treatment of diabetes. Induced pluripotent stem cells (iPSCs) have the potential to generate insulin-producing cells (iβ). However, the gene expression profile and secretory function of iβ still need to be validated in com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellegrini, Silvia, Manenti, Fabio, Chimienti, Raniero, Nano, Rita, Ottoboni, Linda, Ruffini, Francesca, Martino, Gianvito, Ravassard, Philippe, Piemonti, Lorenzo, Sordi, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180725/ https://www.ncbi.nlm.nih.gov/pubmed/30251567 http://dx.doi.org/10.1177/0963689718798564

Ejemplares similares

Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I(−/−) iPSCs for β cell replacement
por: Chimienti, Raniero, et al.
Publicado: (2022)

Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes
por: Pellegrini, Silvia, et al.
Publicado: (2022)

Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
por: Pellegrini, Silvia, et al.
Publicado: (2022)

Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig
por: Kobayashi, Yoshiomi, et al.
Publicado: (2023)

iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)

miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA
por: Marzinotto, Ilaria, et al.
Publicado: (2017)

Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014)

Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming
por: Fu, Kai, et al.
Publicado: (2018)

The potential and challenges of alternative sources of β cells for the cure of type 1 diabetes
por: Cito, Monia, et al.
Publicado: (2018)

Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming
por: Milagre, Inês, et al.
Publicado: (2017)

Derivation of Sendai-Virus-Reprogrammed Human iPSCs-Neuronal Precursors: In Vitro and In Vivo Post-grafting Safety Characterization
por: Shigyo, Michiko, et al.
Publicado: (2023)

Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)

OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
por: Kagawa, Harunobu, et al.
Publicado: (2019)

iPSC reprogramming-mediated aneuploidy correction in autosomal trisomy syndromes
por: Akutsu, Silvia Natsuko, et al.
Publicado: (2022)

Attenuating iPSC reprogramming stress with dominant-negative BET peptides
por: Hossain, Md Emon, et al.
Publicado: (2022)

Intracameral Microimaging of Maturation of Human iPSC Derivatives into Islet Endocrine Cells
por: Zhao, Kaixuan, et al.
Publicado: (2022)

Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level
por: Sui, Dandan, et al.
Publicado: (2014)

Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming
por: Janiszewski, Adrian, et al.
Publicado: (2019)

Clusterin Is Required for β-Amyloid Toxicity in Human iPSC-Derived Neurons
por: Robbins, Jacqueline P., et al.
Publicado: (2018)

Improved Sendai viral system for reprogramming to naive pluripotency
por: Kunitomi, Akira, et al.
Publicado: (2022)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
por: Tang, Yu, et al.
Publicado: (2017)

Transient Acquisition of Pluripotency During Somatic Cell Transdifferentiation with iPSC Reprogramming Factors
por: Maza, Itay, et al.
Publicado: (2015)

An optimized Sendai viral vector platform for reprogramming to naive pluripotency
por: Charlesworth, Carsten T., et al.
Publicado: (2022)

A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species
por: Ogorevc, J., et al.
Publicado: (2016)

Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming
por: Tan, Li, et al.
Publicado: (2017)

Understanding the Molecular Basis of iPSC Reprogrammed Cells to Fulfil Their Expectations in Future Clinical Applications
por: González-Fernández, Verónica, et al.
Publicado: (2022)

Insights into islet development and biology through characterization of a human iPSC-derived endocrine pancreas model
por: van de Bunt, Martijn, et al.
Publicado: (2016)

Islet neogenesis associated protein (INGAP) protects pancreatic β cells from IL-1β and IFNγ-induced apoptosis
por: Nano, Eni, et al.
Publicado: (2021)

Improvement in Mouse iPSC Induction by Rab32 Reveals the Importance of Lipid Metabolism during Reprogramming
por: Pei, Yangli, et al.
Publicado: (2015)

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC
por: Kim, Bu-Yeo, et al.
Publicado: (2016)

Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
por: Tidball, Andrew M., et al.
Publicado: (2017)

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming
por: Generoso, Serena F., et al.
Publicado: (2023)

The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
por: Ou, Zhanhui, et al.
Publicado: (2016)

Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
por: Vethe, Heidrun, et al.
Publicado: (2017)

Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons
por: Sackmann, Christopher, et al.
Publicado: (2020)

TGF-β1 Suppresses Proliferation and Induces Differentiation in Human iPSC Neural in vitro Models
por: Izsak, Julia, et al.
Publicado: (2020)

Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors
por: Nishino, Koichiro, et al.
Publicado: (2018)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_83q3h2ssrotm7h890cpradc753